A Study of Pediatric Patients With Attention Deficit/Hyperactivity Disorder

Clinical trial NCT00922636 · COMPLETED

Trial details

NCT number: NCT00922636
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Attention Deficit Hyperactivity Disorder

Start date: 2009-06-01
Primary completion: 2010-12-01
Enrollment: 340

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.